Genetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene Variant

Cheryl A. Winkler(Kyoto University), William S. Modi(Kyoto University), Michael W. Smith(Kyoto University), George W. Nelson(Kyoto University), Xueyun Wu(Kyoto University), Mary Carrington(Kyoto University), Michael Dean(Kyoto University), T Honjo(Kyoto University), Kai Tashiro(Kyoto University), Daisuke Yabe(Kyoto University), Susan Buchbinder(Kyoto University), Eric Vittinghoff(Kyoto University), James J. Goedert(Kyoto University), Thomas R. OʼBrien(Kyoto University), Lisa P. Jacobson(Kyoto University), Roger Detels(Kyoto University), Sharyne Donfield(Kyoto University), Anne Willoughby(Kyoto University), Edward D. Gomperts(Kyoto University), David Vlahov(Kyoto University), John Phair(Kyoto University), ALIVE Study(Kyoto University), Hemophilia Growth and Development Study (HGDS), San Francisco City Cohort (SFCC), Stephen J. O'Brien(Kyoto University)
Science
January 16, 1998
Cited by 724

Abstract

Stromal-derived factor (SDF-1) is the principal ligand for CXCR4, a coreceptor with CD4 for T lymphocyte cell line-tropic human immunodeficiency virus-type 1 (HIV-1). A common polymorphism, SDF1-3'A, was identified in an evolutionarily conserved segment of the 3' untranslated region of the SDF-1 structural gene transcript. In the homozygous state, SDF1-3'A/3'A delays the onset of acquired immunodeficiency syndrome (AIDS), according to a genetic association analysis of 2857 patients enrolled in five AIDS cohort studies. The recessive protective effect of SDF1-3'A was increasingly pronounced in individuals infected with HIV-1 for longer periods, was twice as strong as the dominant genetic restriction of AIDS conferred by CCR5 and CCR2 chemokine receptor variants in these populations, and was complementary with these mutations in delaying the onset of AIDS.


Related Papers

No related papers found

Powered by citation graph analysis